The latest study on Anti-Obesity Prescription Drugs Market by Read Market Research provides a detailed summary and overview of the global market. The base year considered in this report is considered 2020 whereas information for 2021 is estimated and forecast from 2022 till 2027. The CAGR (Compound Annual Growth Rate) period of this report is 2021-2027. The Global Anti-Obesity Prescription Drugs Market is valued at USD XX Million in the year 2020 and is estimated to grow at USD XX Million by the end of year 2027.The report will shed light on very important growth aspect of Anti-Obesity Prescription Drugs and is a must have data for all the companies, investors, decision makers, top level executives and readers.
The segmental analysis of the report provides detailed analysis on Revenue, Growth, Forecast By Region, Type and Applications for the period 2016-2027.
The major vendors covered:
F Hoffmann La Roche Ltd
Orexigen Therapeutics
Novo Nordisk A/s
Arena Pharmaceuticals
Glaxosmithkline
Vivus
Boehringer Ingelheim
Alizyme
Anti-Obesity Prescription Drugs Market Analysis By Type Segment:
Orlistat
Phentermine and Topiramate
Bupropion and Naltrexone
Lorcaserin
Liraglutide
Anti-Obesity Prescription Drugs Market Analysis By Application Segment:
Pediatric
Adult
Anti-Obesity Prescription Drugs Market Analysis By Regions (Countries):
The Anti-Obesity Prescription Drugs Market has been thoroughly researched with the help of Primary and Secondary Research and has been validated by conduction interviews with industry experts across all the regions. As it is global study, we have included all the major regions.
Bottom Up approach has been used to derive and define the market size and shares of regions. Regions such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. has been taken into consideration while deriving the market size and shares of regions.
Key Details of Regions and Countries of Anti-Obesity Prescription Drugs Report:
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
Key data provided:
Market Size of Regions
Market Share of Regions
Compound Annual Growth Rate (CAGR)
Historic Data From 2016-2020
Forecast Data From 2021-2027
Competitive Landscape of Anti-Obesity Prescription Drugs Market:
Anti-Obesity Prescription Drugs market competitive landscape analysis sheds light on the current market structure by players. The report will help the readers to understand some most important questions of the global market.
Key Questions Answered in Competitive Landscape-
List of Key Players
Revenue By players
Market share of players
Product Offerings
The study objectives are:
To analyze and research the Anti-Obesity Prescription Drugs Market status and future forecast.
To present the key Anti-Obesity Prescription Drugs Market analysis of companies and present revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Anti-Obesity Prescription Drugs Market Size Growth Rate by Type (2016-2027)
1.3.2 Orlistat
1.3.3 Phentermine and Topiramate
1.3.4 Bupropion and Naltrexone
1.3.5 Lorcaserin
1.3.6 Liraglutide
1.4 Market Segment by Application
1.4.1 Global Anti-Obesity Prescription Drugs Market Share by Application (2021-2027)
1.4.2 Pediatric
1.4.3 Adult
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Anti-Obesity Prescription Drugs Market Size
2.1.1 Global Anti-Obesity Prescription Drugs Revenue 2016-2027
2.1.2 Global Anti-Obesity Prescription Drugs Sales 2016-2027
2.2 Anti-Obesity Prescription Drugs Growth Rate by Regions
2.2.1 Global Anti-Obesity Prescription Drugs Sales by Regions 2016-2020
2.2.2 Global Anti-Obesity Prescription Drugs Revenue by Regions 2016-2020
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Anti-Obesity Prescription Drugs Sales by Manufacturers
3.1.1 Anti-Obesity Prescription Drugs Sales by Manufacturers 2020
3.1.2 Anti-Obesity Prescription Drugs Sales Market Share by Manufacturers 2020
3.2 Revenue by Manufacturers
3.2.1 Anti-Obesity Prescription Drugs Revenue by Manufacturers (2020)
3.2.2 Anti-Obesity Prescription Drugs Revenue Share by Manufacturers (2020)
3.2.3 Global Anti-Obesity Prescription Drugs Market Concentration Ratio (CR5 and HHI)
3.3 Anti-Obesity Prescription Drugs Price by Manufacturers
3.4 Key Manufacturers Anti-Obesity Prescription Drugs Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Anti-Obesity Prescription Drugs Market
3.6 Key Manufacturers Anti-Obesity Prescription Drugs Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Orlistat Sales and Revenue (2016-2020)
4.1.2 Phentermine and Topiramate Sales and Revenue (2016-2020)
4.1.3 Bupropion and Naltrexone Sales and Revenue (2016-2020)
4.1.4 Lorcaserin Sales and Revenue (2016-2020)
4.1.5 Liraglutide Sales and Revenue (2016-2020)
4.2 Global Anti-Obesity Prescription Drugs Sales Market Share by Type
4.3 Global Anti-Obesity Prescription Drugs Revenue Market Share by Type
4.4 Anti-Obesity Prescription Drugs Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Anti-Obesity Prescription Drugs Sales by Application
6 United States
6.1 United States Anti-Obesity Prescription Drugs Breakdown Data by Company
6.2 United States Anti-Obesity Prescription Drugs Breakdown Data by Type
6.3 United States Anti-Obesity Prescription Drugs Breakdown Data by Application
7 European Union
7.1 European Union Anti-Obesity Prescription Drugs Breakdown Data by Company
7.2 European Union Anti-Obesity Prescription Drugs Breakdown Data by Type
7.3 European Union Anti-Obesity Prescription Drugs Breakdown Data by Application
8 China
8.1 China Anti-Obesity Prescription Drugs Breakdown Data by Company
8.2 China Anti-Obesity Prescription Drugs Breakdown Data by Type
8.3 China Anti-Obesity Prescription Drugs Breakdown Data by Application
9 Rest of World
9.1 Rest of World Anti-Obesity Prescription Drugs Breakdown Data by Company
9.2 Rest of World Anti-Obesity Prescription Drugs Breakdown Data by Type
9.3 Rest of World Anti-Obesity Prescription Drugs Breakdown Data by Application
9.4 Rest of World Anti-Obesity Prescription Drugs Breakdown Data by Countries
9.4.1 Rest of World Anti-Obesity Prescription Drugs Sales by Countries
9.4.2 Rest of World Anti-Obesity Prescription Drugs Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 F Hoffmann La Roche Ltd
10.1.1 F Hoffmann La Roche Ltd Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Anti-Obesity Prescription Drugs
10.1.4 Anti-Obesity Prescription Drugs Product Introduction
10.1.5 F Hoffmann La Roche Ltd Recent Development
10.2 Orexigen Therapeutics
10.2.1 Orexigen Therapeutics Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Anti-Obesity Prescription Drugs
10.2.4 Anti-Obesity Prescription Drugs Product Introduction
10.2.5 Orexigen Therapeutics Recent Development
10.3 Novo Nordisk A/s
10.3.1 Novo Nordisk A/s Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Anti-Obesity Prescription Drugs
10.3.4 Anti-Obesity Prescription Drugs Product Introduction
10.3.5 Novo Nordisk A/s Recent Development
10.4 Arena Pharmaceuticals
10.4.1 Arena Pharmaceuticals Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Anti-Obesity Prescription Drugs
10.4.4 Anti-Obesity Prescription Drugs Product Introduction
10.4.5 Arena Pharmaceuticals Recent Development
10.5 Glaxosmithkline
10.5.1 Glaxosmithkline Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Anti-Obesity Prescription Drugs
10.5.4 Anti-Obesity Prescription Drugs Product Introduction
10.5.5 Glaxosmithkline Recent Development
10.6 Vivus
10.6.1 Vivus Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Anti-Obesity Prescription Drugs
10.6.4 Anti-Obesity Prescription Drugs Product Introduction
10.6.5 Vivus Recent Development
10.7 Boehringer Ingelheim
10.7.1 Boehringer Ingelheim Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Anti-Obesity Prescription Drugs
10.7.4 Anti-Obesity Prescription Drugs Product Introduction
10.7.5 Boehringer Ingelheim Recent Development
10.8 Alizyme
10.8.1 Alizyme Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Anti-Obesity Prescription Drugs
10.8.4 Anti-Obesity Prescription Drugs Product Introduction
10.8.5 Alizyme Recent Development
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Anti-Obesity Prescription Drugs Sales Channels
11.2.2 Anti-Obesity Prescription Drugs Distributors
11.3 Anti-Obesity Prescription Drugs Customers
12 Market Forecast
12.1 Global Anti-Obesity Prescription Drugs Sales and Revenue Forecast 2021-2027
12.2 Global Anti-Obesity Prescription Drugs Sales Forecast by Type
12.3 Global Anti-Obesity Prescription Drugs Sales Forecast by Application
12.4 Anti-Obesity Prescription Drugs Forecast by Regions
12.4.1 Global Anti-Obesity Prescription Drugs Sales Forecast by Regions 2021-2027
12.4.2 Global Anti-Obesity Prescription Drugs Revenue Forecast by Regions 2021-2027
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables and Figures
List of Tables and Figures
Figure Anti-Obesity Prescription Drugs Product Picture
Table Anti-Obesity Prescription Drugs Key Market Segments
Table Major Manufacturers Anti-Obesity Prescription Drugs Covered in This Report
Table Global Anti-Obesity Prescription Drugs Market Size Growth Rate by Type 2021-2027 (K MT) & (Million US$)
Figure Global Anti-Obesity Prescription Drugs Sales Market Shar by Type 2016-2027
Figure Orlistat Figures
Table Major Manufacturers of Orlistat
Figure Phentermine and Topiramate Figures
Table Major Manufacturers of Phentermine and Topiramate
Figure Bupropion and Naltrexone Figures
Table Major Manufacturers of Bupropion and Naltrexone
Figure Lorcaserin Figures
Table Major Manufacturers of Lorcaserin
Figure Liraglutide Figures
Table Major Manufacturers of Liraglutide
Table Global Anti-Obesity Prescription Drugs Market Share by Application 2021-2027 (K MT)
Figure Pediatric Use Case
Figure Adult Use Case
Figure Anti-Obesity Prescription Drugs Report Years Considered
Figure Global Anti-Obesity Prescription Drugs Market Size 2016-2027 (Million US$)
Figure Global Anti-Obesity Prescription Drugs Sales 2016-2020 (K MT)
Table Global Anti-Obesity Prescription Drugs Market Size by Regions 2016-2020 (K MT) & (Million US$)
Table Global Anti-Obesity Prescription Drugs Sales by Regions 2016-2020 (K MT)
Table Global Anti-Obesity Prescription Drugs Sales Market Share by Regions 2016-2020
Figure Global Anti-Obesity Prescription Drugs Sales Market Share by Regions 2016-2020
Figure Global Anti-Obesity Prescription Drugs Sales Market Share by Regions in 2020
Table Global Anti-Obesity Prescription Drugs Revenue by Regions 2016-2020 (Million US$)
Table Global Anti-Obesity Prescription Drugs Revenue Market Share by Regions 2016-2020
Figure Global Anti-Obesity Prescription Drugs Revenue Market Share by Regions 2016-2020
Figure Global Anti-Obesity Prescription Drugs Revenue Market Share by Regions in 2020
Table Market Top Trends
Table Global Anti-Obesity Prescription Drugs Sales by Manufacturers (2020) (K MT)
Table Global Anti-Obesity Prescription Drugs Sales Share by Manufacturers (2020)
Figure Global Anti-Obesity Prescription Drugs Sales Share by Manufacturers in 2020
Table Anti-Obesity Prescription Drugs Revenue by Manufacturers (2020) (Million USD)
Table Anti-Obesity Prescription Drugs Revenue Share by Manufacturers (2020)
Figure Anti-Obesity Prescription Drugs Value Share by Manufacturers in 2020
Table Global Anti-Obesity Prescription Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Anti-Obesity Prescription Drugs Price (2016-2020) (USD/MT)
Table Key Manufacturers Anti-Obesity Prescription Drugs Plants/Factories Distribution
Table Key Manufacturers Anti-Obesity Prescription Drugs Area Served
Table Date of Key Manufacturers Enter into Anti-Obesity Prescription Drugs Market
Table Key Manufacturers Anti-Obesity Prescription Drugs Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global Orlistat Sales and Revenue (2016-2020) (K MT) & (Million US$)
Table Global Phentermine and Topiramate Sales and Revenue (2016-2020) (K MT) & (Million US$)
Table Global Bupropion and Naltrexone Sales and Revenue (2016-2020) (K MT) & (Million US$)
Table Global Lorcaserin Sales and Revenue (2016-2020) (K MT) & (Million US$)
Table Global Liraglutide Sales and Revenue (2016-2020) (K MT) & (Million US$)
Table Global Anti-Obesity Prescription Drugs Sales by Type (2016-2020) (K MT)
Table Global Anti-Obesity Prescription Drugs Sales Share by Type (2016-2020)
Figure Global Anti-Obesity Prescription Drugs Sales Market Share by Type (2016-2020)
Figure Global Anti-Obesity Prescription Drugs Sales Market Share by Type in 2020
Table Global Anti-Obesity Prescription Drugs Revenue by Type (2016-2020) (Million US$)
Table Global Anti-Obesity Prescription Drugs Revenue Share by Type (2016-2020)
Figure Global Anti-Obesity Prescription Drugs Revenue Market Share by Type (2016-2020)
Figure Global Anti-Obesity Prescription Drugs Revenue Market Share by Type in 2020
Table Anti-Obesity Prescription Drugs Price by Type 2016-2020 (USD/MT)
Table Global Anti-Obesity Prescription Drugs Sales by Application (2016-2020) (K MT)
Table Global Anti-Obesity Prescription Drugs Sales Share by Application (2016-2020)
Figure Global Sales Anti-Obesity Prescription Drugs Market Share by Application (2016-2020)
Figure Global Sales Anti-Obesity Prescription Drugs Market Share by Application (2016-2020)
Figure United States Anti-Obesity Prescription Drugs Sales Growth Rate 2016-2020 (K MT)
Figure United States Anti-Obesity Prescription Drugs Revenue Growth Rate 2016-2020 (Million US$)
Table United States Anti-Obesity Prescription Drugs Sales by Company (2020) (K MT)
Table United States Anti-Obesity Prescription Drugs Sales Market Share by Company (2020)
Figure United States Anti-Obesity Prescription Drugs Sales Market Share by Company in 2020
Table United States Anti-Obesity Prescription Drugs Sales by Type (2016-2020) (K MT)
Table United States Anti-Obesity Prescription Drugs Sales Market Share by Type (2016-2020)
Figure United States Anti-Obesity Prescription Drugs Market Share by Type in 2020
Table United States Anti-Obesity Prescription Drugs Sales by Application (2016-2020) (K MT)
Table United States Anti-Obesity Prescription Drugs Sales Market Share by Application (2016-2020)
Figure United States Anti-Obesity Prescription Drugs Market Share by Application in 2020
Figure European Union Anti-Obesity Prescription Drugs Sales Growth Rate 2016-2020 (K MT)
Figure European Union Anti-Obesity Prescription Drugs Revenue Growth Rate 2016-2020 (Million US$)
Table European Union Anti-Obesity Prescription Drugs Sales by Company (2020) (K MT)
Table European Union Anti-Obesity Prescription Drugs Sales Market Share by Company (2020)
Figure European Union Anti-Obesity Prescription Drugs Sales Market Share by Company in 2020
Table European Union Anti-Obesity Prescription Drugs Sales by Type (2016-2020) (K MT)
Table European Union Anti-Obesity Prescription Drugs Sales Market Share by Type (2016-2020)
Figure 2020 European Union Anti-Obesity Prescription Drugs Market Share by Type
Table European Union Anti-Obesity Prescription Drugs Sales by Application (2016-2020) (K MT)
Table European Union Anti-Obesity Prescription Drugs Sales Market Share by Application (2016-2020)
Figure 2020 European Union Anti-Obesity Prescription Drugs Market Share by Application
Figure China Anti-Obesity Prescription Drugs Sales Growth Rate 2016-2020 (K MT)
Figure China Anti-Obesity Prescription Drugs Revenue Growth Rate 2016-2020 (Million US$)
Table China Anti-Obesity Prescription Drugs Sales by Company (2020) (K MT)
Table China Anti-Obesity Prescription Drugs Sales Market Share by Company (2020)
Figure China Anti-Obesity Prescription Drugs Sales Market Share by Company in 2020
Table China Anti-Obesity Prescription Drugs Sales by Type (2016-2020) (K MT)
Table China Anti-Obesity Prescription Drugs Sales Market Share by Type (2016-2020)
Figure China Anti-Obesity Prescription Drugs Market Share by Type in 2020
Table China Anti-Obesity Prescription Drugs Sales by Application (2016-2020) (K MT)
Table China Anti-Obesity Prescription Drugs Sales Market Share by Application (2016-2020)
Figure China Anti-Obesity Prescription Drugs Market Share by Application in 2020
Figure Rest of World Anti-Obesity Prescription Drugs Sales Growth Rate 2016-2020 (K MT)
Figure Rest of World Anti-Obesity Prescription Drugs Revenue Growth Rate 2016-2020 (Million US$)
Table Rest of World Anti-Obesity Prescription Drugs Sales by Company (2020) (K MT)
Table Rest of World Anti-Obesity Prescription Drugs Sales Market Share by Company (2020)
Figure Rest of World Anti-Obesity Prescription Drugs Sales Market Share by Company in 2020
Table Rest of World Anti-Obesity Prescription Drugs Sales by Type (2016-2020) (K MT)
Table Rest of World Anti-Obesity Prescription Drugs Sales Market Share by Type (2016-2020)
Figure Rest of World Anti-Obesity Prescription Drugs Market Share by Type in 2020
Table Rest of World Anti-Obesity Prescription Drugs Sales by Application (2016-2020) (K MT)
Table Rest of World Anti-Obesity Prescription Drugs Sales Market Share by Application (2016-2020)
Figure Rest of World Anti-Obesity Prescription Drugs Market Share by Application in 2020
Table Rest of World Anti-Obesity Prescription Drugs Sales by Countries (2016-2020) (K MT)
Table Rest of World Anti-Obesity Prescription Drugs Sales Market Share by Countries (2016-2020)
Figure Rest of World Anti-Obesity Prescription Drugs Sales Market Share by Countries in 2020
Table Rest of World Anti-Obesity Prescription Drugs Revenue by Countries (2016-2020) (Million US$)
Table Rest of World Anti-Obesity Prescription Drugs Revenue Market Share by Countries (2016-2020)
Figure Rest of World Anti-Obesity Prescription Drugs Revenue Market Share by Countries in 2020
Figure Japan Anti-Obesity Prescription Drugs Sales Growth Rate (2016-2020) (K MT)
Figure Japan Anti-Obesity Prescription Drugs Revenue Growth Rate (2016-2020) (K MT)
Figure Korea Anti-Obesity Prescription Drugs Sales Growth Rate (2016-2020) (K MT)
Figure Korea Anti-Obesity Prescription Drugs Revenue Growth Rate (2016-2020) (K MT)
Figure India Anti-Obesity Prescription Drugs Sales Growth Rate (2016-2020) (K MT)
Figure India Anti-Obesity Prescription Drugs Revenue Growth Rate (2016-2020) (K MT)
Figure Southeast Asia Anti-Obesity Prescription Drugs Sales Growth Rate (2016-2020) (K MT)
Figure Southeast Asia Anti-Obesity Prescription Drugs Revenue Growth Rate (2016-2020) (K MT)
Table F Hoffmann La Roche Ltd Company Details
Table F Hoffmann La Roche Ltd Description and Business Overview
Table F Hoffmann La Roche Ltd Anti-Obesity Prescription Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2020)
Table F Hoffmann La Roche Ltd Anti-Obesity Prescription Drugs Sales Growth Rate (2016-2020)
Table F Hoffmann La Roche Ltd Anti-Obesity Prescription Drugs Sales Market Share in Global Market
Table F Hoffmann La Roche Ltd Recent Development
Table Orexigen Therapeutics Company Details
Table Orexigen Therapeutics Description and Business Overview
Table Orexigen Therapeutics Anti-Obesity Prescription Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2020)
Table Orexigen Therapeutics Anti-Obesity Prescription Drugs Sales Growth Rate (2016-2020)
Table Orexigen Therapeutics Anti-Obesity Prescription Drugs Sales Market Share in Global Market
Table Orexigen Therapeutics Recent Development
Table Novo Nordisk A/s Company Details
Table Novo Nordisk A/s Description and Business Overview
Table Novo Nordisk A/s Anti-Obesity Prescription Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2020)
Table Novo Nordisk A/s Anti-Obesity Prescription Drugs Sales Growth Rate (2016-2020)
Table Novo Nordisk A/s Anti-Obesity Prescription Drugs Sales Market Share in Global Market
Table Novo Nordisk A/s Recent Development
Table Arena Pharmaceuticals Company Details
Table Arena Pharmaceuticals Description and Business Overview
Table Arena Pharmaceuticals Anti-Obesity Prescription Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2020)
Table Arena Pharmaceuticals Anti-Obesity Prescription Drugs Sales Growth Rate (2016-2020)
Table Arena Pharmaceuticals Anti-Obesity Prescription Drugs Sales Market Share in Global Market
Table Arena Pharmaceuticals Recent Development
Table Glaxosmithkline Company Details
Table Glaxosmithkline Description and Business Overview
Table Glaxosmithkline Anti-Obesity Prescription Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2020)
Table Glaxosmithkline Anti-Obesity Prescription Drugs Sales Growth Rate (2016-2020)
Table Glaxosmithkline Anti-Obesity Prescription Drugs Sales Market Share in Global Market
Table Glaxosmithkline Recent Development
Table Vivus Company Details
Table Vivus Description and Business Overview
Table Vivus Anti-Obesity Prescription Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2020)
Table Vivus Anti-Obesity Prescription Drugs Sales Growth Rate (2016-2020)
Table Vivus Anti-Obesity Prescription Drugs Sales Market Share in Global Market
Table Vivus Recent Development
Table Boehringer Ingelheim Company Details
Table Boehringer Ingelheim Description and Business Overview
Table Boehringer Ingelheim Anti-Obesity Prescription Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2020)
Table Boehringer Ingelheim Anti-Obesity Prescription Drugs Sales Growth Rate (2016-2020)
Table Boehringer Ingelheim Anti-Obesity Prescription Drugs Sales Market Share in Global Market
Table Boehringer Ingelheim Recent Development
Table Alizyme Company Details
Table Alizyme Description and Business Overview
Table Alizyme Anti-Obesity Prescription Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2020)
Table Alizyme Anti-Obesity Prescription Drugs Sales Growth Rate (2016-2020)
Table Alizyme Anti-Obesity Prescription Drugs Sales Market Share in Global Market
Table Alizyme Recent Development
Figure Anti-Obesity Prescription Drugs Value Chain
Table Anti-Obesity Prescription Drugs Distributors List
Table Anti-Obesity Prescription Drugs Customers List
Table Global Anti-Obesity Prescription Drugs Sales Forecast 2021-2027 (K MT) & (Million US$)
Figure Global Anti-Obesity Prescription Drugs Sales Forecast 2021-2027 (K MT)
Figure Global Anti-Obesity Prescription Drugs Revenue Forecast 2021-2027 (Million US$)
Table Global Anti-Obesity Prescription Drugs Sales Forecast by Type 2021-2027 (K MT)
Figure Global Anti-Obesity Prescription Drugs Sales Forecast by Type 2021-2027 (K MT)
Figure Global Anti-Obesity Prescription Drugs Sales Market Share Forecast by Type 2021-2027
Table Global Anti-Obesity Prescription Drugs Sales Forecast by Application 2021-2027 (K MT)
Figure Global Anti-Obesity Prescription Drugs Sales Forecast by Application 2021-2027 (K MT)
Figure Global Anti-Obesity Prescription Drugs Sales Market Share Forecast by Application 2021-2027
Table Global Anti-Obesity Prescription Drugs Sales Forecast by Regions 2021-2027 (K MT)
Figure Global Anti-Obesity Prescription Drugs Sales Forecast by Regions 2021-2027 (K MT)
Figure Global Anti-Obesity Prescription Drugs Sales Market Share Forecast by Regions 2021-2027
Table Global Anti-Obesity Prescription Drugs Revenue Forecast by Regions 2021-2027 (K MT)
Figure Global Anti-Obesity Prescription Drugs Revenue Forecast by Regions 2021-2027 (K MT)
Figure Global Anti-Obesity Prescription Drugs Revenue Market Share Forecast by Regions 2021-2027
Figure United States Anti-Obesity Prescription Drugs Sales Forecast 2021-2027 (K MT)
Figure United States Anti-Obesity Prescription Drugs Revenue Forecast 2021-2027 (Million US$)
Figure European Union Anti-Obesity Prescription Drugs Sales Forecast 2021-2027 (K MT)
Figure European Union Anti-Obesity Prescription Drugs Revenue Forecast 2021-2027 (Million US$)
Figure China Anti-Obesity Prescription Drugs Sales Forecast 2021-2027 (K MT)
Figure China Anti-Obesity Prescription Drugs Revenue Forecast 2021-2027 (Million US$)
Figure Japan Anti-Obesity Prescription Drugs Sales Forecast 2021-2027 (K MT)
Figure Japan Anti-Obesity Prescription Drugs Revenue Forecast 2021-2027 (Million US$)
Figure Korea Anti-Obesity Prescription Drugs Sales Forecast 2021-2027 (K MT)
Figure Korea Anti-Obesity Prescription Drugs Revenue Forecast 2021-2027 (Million US$)
Figure India Anti-Obesity Prescription Drugs Sales Forecast 2021-2027 (K MT)
Figure India Anti-Obesity Prescription Drugs Revenue Forecast 2021-2027 (Million US$)
Figure Southeast Asia Anti-Obesity Prescription Drugs Sales Forecast 2021-2027 (K MT)
Figure Southeast Asia Anti-Obesity Prescription Drugs Revenue Forecast 2021-2027 (Million US$)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources